檢索結果 - Lars Møller
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Structure of the bacterial cell division determinant GpsB and its interaction with penicillin‐binding proteins 由 Jeanine Rismondo, Robert M. Cleverley, Harriet V. Lane, Stephanie Großhennig, Anne Steglich, Lars Møller, Gopala Krishna Mannala, Torsten Hain, Richard J. Lewis, Sven Halbedel
出版 2015Artigo -
9
Chemoimmunotherapy with ofatumumab in combination with <scp>CHOP</scp> in previously untreated follicular lymphoma 由 Myron S. Czuczman, Georg Heß, Ole Gadeberg, Lars Møller Pedersen, Nancy Goldstein, Ira Gupta, Roxanne C. Jewell, Thomas S. Lin, Steen Lisby, Claus Strange, Kristian Windfeld, Andreas Viardot
出版 2012Artigo -
10
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands 由 Maria Skaalum Petersen, Sunnvør í Kongsstovu, Eina H. Eliasen, Sólrun Larsen, Jóhanna Ljósá Hansen, Nicolina Vest, Maria Marjunardóttir Dahl, Debes Hammershaimb Christiansen, Lars Møller, Marnar Fríðheim Kristiansen
出版 2022Artigo -
11
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma 由 Martin Hutchings, Annika Loft, Mads Hansen, Lars Møller Pedersen, Thora Buhl, Jesper Jurlander, Simon Buus, Susanne Keiding, Francesco d’Amore, A. M. Boesen, Anne Kiil Berthelsen, Lena Specht
出版 2005Artigo -
12
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas 由 P. Brown, Kah Keng Wong, Suet Ling Felce, Linden Lyne, Hayley Spearman, Elizabeth J. Soilleux, Lars Møller Pedersen, Michael Møller, T M Green, D. M. Gascoyne, Alison H. Banham
出版 2015Artigo -
13
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vinc... 由 Tina Green, Ken H. Young, Carlo Visco, Zijun Y. Xu‐Monette, Attilio Orazi, Ronald S. Go, Ole Nielsen, Ole Gadeberg, Torben Mourits‐Andersen, Mikael Frederiksen, Lars Møller Pedersen, Michael Møller
出版 2012Artigo -
14
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study 由 Anna Abrahamsson, Alexandra Albertsson‐Lindblad, Peter de Nully Brown, Stefanie Baumgartner-Wennerholm, Lars Møller Pedersen, Francesco d’Amore, Herman Nilsson‐Ehle, Paw Jensen, Michael Pedersen, Christian H. Geisler, Mats Jerkeman
出版 2014Artigo -
15
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands 由 Maria Skaalum Petersen, Marin Strøm, Debes Hammershaimb Christiansen, Jógvan Páll Fjallsbak, Eina H. Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Shahin Gaïni, Lars Møller, Bjarni á Steig, Pál Weihe
出版 2020Artigo -
16
Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity 由 Raquel Alonso‐Román, Antonia Last, Mohammad H. Mirhakkak, Jakob L. Sprague, Lars Møller, Peter Großmann, Katja Graf, Rena Gratz, Selene Mogavero, Slavena Vylkova, Gianni Panagiotou, Sascha Schäuble, Bernhard Hube, Mark S. Gresnigt
出版 2022Artigo -
17
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy 由 Ahmad, Shamaila Munir, Martinenaite, Evelina, Holmström, Morten, Jørgensen, Mia Aaboe, Met, Özcan, Nastasi, Claudia, Klausen, Uffe, Donia, Marco, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders, Svane, Inge Marie, Andersen, Mads Hald
出版 2017Text -
18
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma 由 Taskinen, Minna, Louhimo, Riku, Koivula, Satu, Chen, Ping, Rantanen, Ville, Holte, Harald, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Björkholm, Magnus, Fluge, Øystein, Pedersen, Lars Møller, Fjordén, Karin, Jerkeman, Mats, Eriksson, Mikael, Hautaniemi, Sampsa, Leppä, Sirpa
出版 2014Text -
19
Reduced expression of <scp>TRIM</scp>21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease 由 Susanna Brauner, Wei Zhou, Carin Backlin, Tina M. Green, Lasse Folkersen, Margarita Ivanchenko, Björn Löfström, Ziju Y. Xu-Monette, Ken H. Young, Lars Møller Pedersen, Michael Møller, Christer Sundström, Gunilla Enblad, Eva Baecklund, Marie Wahren‐Herlenius
出版 2015Artigo -
20
The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial 由 Anne Juul Wikkelsoe, Arash Afshari, Jakob Stensballe, Jens Langhoff‐Roos, Charlotte Albrechtsen, Kim Ekelund, Gabriele Hanke, Heidi Sharif, Anja U. Mitchell, Jens Svare, Ane Troelstrup, Lars Møller Pedersen, Jeannet Lauenborg, Mette Gøttge Madsen, Birgit Bødker, Ann Merete Møller
出版 2012Artigo
相關主題
Medicine
Internal medicine
Biology
Lymphoma
Oncology
Immunology
Genetics
Pathology
Rituximab
Disease
Gastroenterology
Chemotherapy
Coronavirus disease 2019 (COVID-19)
Diffuse large B-cell lymphoma
Follicular lymphoma
Gene
Infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Surgery
Virology
Antibody
Biochemistry
CHOP
Cancer research
Microbiology
Outbreak
Physics
2019-20 coronavirus outbreak
B cell
Bacteria